Dr. Imran Nisar Shaikh

Dr Imran Nisar Shaikh is a highly advanced Medical Oncologist in Mumbai with 16 years of elite clinical experience in precision medicine, targeted cancer therapies, and advanced immuno-oncology.

He currently serves as a Consultant in Medical Oncology at the prestigious Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute in Andheri West.

He is fluent in English, Hindi, and Marathi, ensuring highly empathetic and crystal-clear communication with patients navigating complex cancer diagnoses.

Demonstrating immense clinical authority, Dr Shaikh is a master of Precision Medicine. Instead of relying solely on traditional, toxic chemotherapy, he utilizes bleeding-edge molecular diagnostics—including Next Generation Sequencing (NGS) and Liquid Biopsies—to physically map the DNA mutations of a patient's tumor.

This allows him to architect highly customized, targeted therapies that hunt down and destroy specific cancer cells while sparing healthy tissue.

He is a globally published clinical researcher and a definitive authority on Immunotherapy. His massive 2024-2026 publication footprint in apex oncology journals details his breakthrough use of immune checkpoint inhibitors to achieve total cures in metastatic colorectal and ovarian cancers.

He brings decades of formidable clinical leadership to his practice, having previously managed severe oncology cases as a Consultant at several renowned facilities, including Jaslok Hospital, Saifee Hospital, and Sushrut Hospital.

Specialty Areas and Treatments

Dr Imran Nisar Shaikh provides world-class, technology-driven oncological care, utilizing advanced molecular profiling to design personalized, highly lethal treatments against solid tumors and blood cancers.

Precision Medicine and Targeted Therapy

He utilizes extreme-precision DNA sequencing to deploy customized molecular weapons against cancer:

• Advanced Targeted Therapies for Metastatic Breast, Lung, and Prostate Cancers
• Next Generation Sequencing (NGS) and Liquid Biopsy Analysis
• Immunohistochemistry (IHC) Guided Personalized Medicine

Advanced Immuno-Oncology

He utilizes bleeding-edge medications to weaponize the patient's own immune system against the tumor:

• Immune Checkpoint Inhibitors for Metastatic Colorectal Carcinoma
• Microsatellite Instability (MSI) Guided Immunotherapy

Complex Chemotherapy Administration

He executes rigorous chemical protocols to destroy aggressive cancers:

• Complex Intrathecal Chemotherapy (Administered directly into the spinal fluid)
• Systemic Chemotherapy for Solid Tumors and Blood Cancers
• Advanced Management of Chemotherapy Toxicity and Side Effects
• Vascular Catheter and Port Placements

Education and Qualifications

• MBBS — BJ Medical College, Pune
• MD in Internal Medicine — BJ Medical College, Pune
• DNB in Medical Oncology — Jaslok Hospital and Research Centre, Mumbai

Publications and Research

Dr Shaikh is a globally recognized oncology researcher, publishing heavily on genetic mutations, immunotherapy, and metastatic cancer in 2024-2026:

• Kaler AK, Patil A, Kulkarni Y, et al. (2026). Germline Mutational Spectrum in Ovarian Cancer: A Descriptive Study from a Tertiary Cancer Center. Indian J Med Paediatr Oncol.
• Kaler AK, Mulchandani M, Shaikh I, et al. (2025). Integration of Molecular Profiling with Microsatellite Instability in Metastatic Colorectal Cancers. JCTR.
• Fatima S, Shaikh IN, et al. (2025). Clinicopathological characteristics and oncological outcomes in a case of primary ovarian adenosarcoma with sarcomatous differentiation: a case report and literature review. Int J Reprod Contracept Obstet Gynecol.
• Kaler AK, Jethani M, Nadkarni M, et al. (2025). Molecular Subtyping and Classification of PIK3CA Mutations in Metastatic Breast Cancer. Curr Tissue Microenviron Rep.
• Kaler AK, Fatima S, Dhurat O, et al. (2024). Role of Microsatellite Instability as Pan-Cancer Agnostic Marker of Solid Tumours in Personalized Medicine. Curr Tissue Microenviron Rep.
• Fatima S, Shaikh IN, Athikari N. (2024). Durable response to docetaxel in a case of primary seminal vesicle adenocarcinoma with zinner syndrome. Journal of Cancer Research and Therapeutics.
• Dhamani AM, Sheth HS, Bhattacharyya S, Shaikh IN. (2021). Paradigm shift from palliation to cure in metastatic microsatellite high colorectal carcinoma with immune checkpoint inhibitors. Journal of Cancer Research and Therapeutics.

Professional Memberships

• European Society of Medical Oncology (ESMO)
• Indian Cooperative Oncology Network (ICON)

Professional Experience

Dr Imran Nisar Shaikh currently practises at the following facilities:

• Consultant, Medical Oncology, Kokilaben Dhirubhai Ambani Hospital And Medical Research Institute in Andheri West
• Consultant (Former), Jaslok Hospital And Research Centre, Tardeo
• Consultant (Former), Saifee Hospital, Girgaon
• Consultant (Former), Sushrut Hospital And Research Centre, Chembur
• Consultant (Former), Inlaks and Budhrani Hospital, Pune

Book an Appointment with Dr Imran Nisar Shaikh

To book an appointment with Dr Imran Nisar Shaikh or to check OPD timings and consultation details at Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute in Andheri West in Mumbai, connect with the HexaHealth team for assistance.